Intravenous Ibuprofen Versus Ketorolac in Bariatric Surgery
Postoperative Pain, Bariatric Surgery Candidate
About this trial
This is an interventional treatment trial for Postoperative Pain
Eligibility Criteria
Inclusion Criteria: adult (18-65 years) patients body mass index ≥35 kg/m2 scheduled for laparoscopic bariatric surgery Exclusion Criteria: American Society of Anesthesiologists (ASA) physical class IV, severe cardiac comorbidity (impaired contractility with ejection fraction < 50%, heart block, significant arrhythmias, tight valvular lesions), known obstructive sleep apnea or patients with STOP-bang score ≥5, baseline SpO2 <95%, renal impairment, allergy to any of study's drugs, history of gastrointestinal bleeding or ulceration, or inflammatory bowel disease
Sites / Locations
- Cairo University
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Ketorolac group
Ibuprofen group
ketorolac 30 mg (diluted in 200 mL normal saline) intravenously over 5 minutes
ibuprofen 800 mg intravenously (Diluted in 200 mL of normal saline) over 5 minutes